Literature DB >> 27527585

Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.

Michelle L Pershing1, David Phenis2, Valentina Valentini3, Ana Pocivavsek4, Derick H Lindquist1,2, Robert Schwarcz4, John P Bruno5,6.   

Abstract

RATIONALE: Levels of kynurenic acid (KYNA), an endogenous negative modulator of alpha 7 nicotinic acetylcholine receptors (α7nAChRs) and antagonist at glutamatergic N-methyl-D-aspartate receptors (NMDARs), are elevated in the brain of patients with schizophrenia (SZ). In rats, dietary exposure to KYNA's immediate precursor kynurenine during the last week of gestation produces neurochemical and cognitive deficits in adulthood that resemble those seen in patients with SZ.
OBJECTIVES: The present experiments examined whether prenatal kynurenine exposure results in age-dependent changes in the kynurenine pathway (KP), expression of selected receptors, and cognitive function.
METHODS: Pregnant dams were fed unadulterated mash (progeny = ECON) or mash containing kynurenine (100 mg/day; progeny = EKYN) from embryonic day (ED) 15 to 22. Male offspring were assessed as juveniles, i.e., prior to puberty (postnatal day [PD] 32), or as adults (PD70) for brain KYNA levels, α7nAChR and NMDAR gene expression, and performance on a trace fear conditioning (TFC) task.
RESULTS: KYNA levels were comparable between juvenile ECON and EKYN rats, whereas EKYN adults exhibited a ~3-fold increase in brain KYNA relative to ECONs. NR2A expression was persistently reduced (30-40 %) in EKYN rats at both ages. Compared to ECON adults, there was a 50 % reduction in NR1, and a trend toward decreased α7nAChR expression, in adult EKYN rats. Surprisingly, juvenile EKYN rats performed significantly better in the TFC paradigm than controls, whereas adult EKYN animals showed the predicted deficits.
CONCLUSIONS: Collectively, our results provide evidence that KP changes in the fetal brain alter neuronal development and cause age-dependent effects on neurochemistry and cognitive performance.

Entities:  

Keywords:  Glutamate; Kynurenic acid; N-Methyl-D-aspartate receptors; Prefrontal cortex; Schizophrenia; Trace fear conditioning; alpha7 nicotinic receptors

Mesh:

Substances:

Year:  2016        PMID: 27527585      PMCID: PMC5808405          DOI: 10.1007/s00213-016-4404-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  78 in total

1.  Myogenic factors that regulate expression of muscle-specific microRNAs.

Authors:  Prakash K Rao; Roshan M Kumar; Mina Farkhondeh; Scott Baskerville; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

2.  Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.

Authors:  Ikwunga Wonodi; O Colin Stine; Korrapati V Sathyasaikumar; Rosalinda C Roberts; Braxton D Mitchell; L Elliot Hong; Yasushi Kajii; Gunvant K Thaker; Robert Schwarcz
Journal:  Arch Gen Psychiatry       Date:  2011-07

Review 3.  Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: facts and challenges.

Authors:  Edson X Albuquerque; Robert Schwarcz
Journal:  Biochem Pharmacol       Date:  2012-12-25       Impact factor: 5.858

4.  Temporal context discrimination in patients with schizophrenia: associations with auditory hallucinations and negative symptoms.

Authors:  Gildas Brébion; Anthony S David; Hugh M Jones; Ruth Ohlsen; Lyn S Pilowsky
Journal:  Neuropsychologia       Date:  2006-09-22       Impact factor: 3.139

Review 5.  Prefrontal cortical regulation of fear learning.

Authors:  Marieke R Gilmartin; Nicholas L Balderston; Fred J Helmstetter
Journal:  Trends Neurosci       Date:  2014-06-11       Impact factor: 13.837

Review 6.  Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

Authors:  Michael F Green; Robert S Kern; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

7.  Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles.

Authors:  Kevin Erreger; Shashank M Dravid; Tue G Banke; David J A Wyllie; Stephen F Traynelis
Journal:  J Physiol       Date:  2005-01-13       Impact factor: 5.182

Review 8.  Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.

Authors:  Sophie Erhardt; Sara K Olsson; Göran Engberg
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

9.  Context memory and binding in schizophrenia.

Authors:  Flavie A V Waters; Murray T Maybery; Johanna C Badcock; Patricia T Michie
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

10.  Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine.

Authors:  C M Forrest; K McNair; M Pisar; O S Khalil; L G Darlington; T W Stone
Journal:  Neuroscience       Date:  2015-09-10       Impact factor: 3.590

View more
  12 in total

1.  Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.

Authors:  Francesca M Notarangelo; Sarah Beggiato; Robert Schwarcz
Journal:  Dev Neurosci       Date:  2019-05-22       Impact factor: 2.984

2.  Quantitative Analysis of Kynurenine Aminotransferase II in the Adult Rat Brain Reveals High Expression in Proliferative Zones and Corpus Callosum.

Authors:  Chang Song; Sarah M Clark; Chloe N Vaughn; James D Nicholson; Kelley J Murphy; Ta-Chung M Mou; Robert Schwarcz; Gloria E Hoffman; Leonardo H Tonelli
Journal:  Neuroscience       Date:  2017-11-08       Impact factor: 3.590

3.  Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood.

Authors:  Britta Hahn; Carolyn H Reneski; Ana Pocivavsek; Robert Schwarcz
Journal:  Psychopharmacology (Berl)       Date:  2017-11-11       Impact factor: 4.530

4.  Prior stress followed by a novel stress challenge results in sex-specific deficits in behavioral flexibility and changes in gene expression in rat medial prefrontal cortex.

Authors:  Kelly M Moench; Michaela R Breach; Cara L Wellman
Journal:  Horm Behav       Date:  2019-10-23       Impact factor: 3.587

5.  Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.

Authors:  D M Bortz; H-Q Wu; R Schwarcz; J P Bruno
Journal:  Neuropharmacology       Date:  2017-04-15       Impact factor: 5.250

6.  Preferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid.

Authors:  Eden Flores-Barrera; Daniel R Thomases; Daryn K Cass; Ajay Bhandari; Robert Schwarcz; John P Bruno; Kuei Y Tseng
Journal:  J Neurosci       Date:  2017-07-20       Impact factor: 6.167

7.  Exposure to elevated embryonic kynurenine in rats: Sex-dependent learning and memory impairments in adult offspring.

Authors:  Silas A Buck; Annalisa M Baratta; Ana Pocivavsek
Journal:  Neurobiol Learn Mem       Date:  2020-07-30       Impact factor: 2.877

8.  Exposure to intrauterine inflammation alters metabolomic profiles in the amniotic fluid, fetal and neonatal brain in the mouse.

Authors:  Amy G Brown; Natalia M Tulina; Guillermo O Barila; Michael S Hester; Michal A Elovitz
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

9.  A single prenatal lipopolysaccharide injection has acute, but not long-lasting, effects on cerebral kynurenine pathway metabolism in mice.

Authors:  Francesca M Notarangelo; Robert Schwarcz
Journal:  Eur J Neurosci       Date:  2021-08-17       Impact factor: 3.698

Review 10.  Cross Talk: The Microbiota and Neurodevelopmental Disorders.

Authors:  John R Kelly; Chiara Minuto; John F Cryan; Gerard Clarke; Timothy G Dinan
Journal:  Front Neurosci       Date:  2017-09-15       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.